MILV, JVA, RAYS – Hot Stocks Today

MILV was a heck of a call on our part, after our afternoon momentum alert yesterday (@.055), the stock managed to hit .0635, and even close out the day just one tick shy of its high-of-day.

Its a good sign to see a running stock close with strength, so we will certainly be monitoring MILV this morning to see if it can close out the week in similar fashion.

In addition to several promotions this morning (That does not include us, just to clear things up. We are rarely paid for the stocks we mention. If we are, it always appears directly below in our disclaimer.) the company had more news out:

CAPE CORAL, Fla., Oct. 28, 2011 /PRNewswire via COMTEX/ — Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures (MILV.pk), has entered into the $8.4 billion market chronic obstructive pulmonary disease market (COPD) with the completed acquisition of a ground breaking Breathing Formula. This all natural, non-synthetic, medicine was developed for the treatment of COPD, the two most common forms of which are Emphysema and Chronic Bronchitis. We believe that there is no other product currently available that can achieve the same results.

We jumped on JVA at 8.35, realizing that it was a stock that traded in predictable patterns. That still rings true here in the $10-range, after having pulled slightly back to the 9.70’s on Wednesday.

After a nice recovery on Thursday to the tune of 9.3%, it looks like JVA is poised to head into the weekend strongly.

RAYS continued its seemingly incessant ascension on Thursday, closing at that day’s high of 1.95. It looks like a break of the 2.00 milestone could happen sooner rather than later.

That being said, our prudence, and dedication to you, the reader, dictates we mention one little detail: RAYS is a heavily promoted stock (again, we are not part of those promotions) and while the promo budget is said to have been on the order of more than two million dollars, we have yet to see a press release or any information direct from the company containing anything of real substance.

It isnt enough to scare us completely away from what is obviously a potentially fortuitous situation any way you slice it, but it is enough to keep us on our guard.

Ultimately, we won’t fully relax that wariness until we see something along the lines of a sales agreement, or more detailed information on the company’s lauded video compression technology, which as of now, we have only seen in the form of a sample clip on the company’s website.

us.raystream.com/home